期刊
EUROPEAN HEART JOURNAL SUPPLEMENTS
卷 9, 期 H, 页码 H41-H47出版社
OXFORD UNIV PRESS
DOI: 10.1093/eurheartj/sum054
关键词
biomarkers; pulmonary hypertension; chronic heart failure; right ventricular function; prognosis
Humoral biomarkers emerged within the last decade as an attractive non-invasive tool for assessment and monitoring of right ventricular (RV) dysfunction in patients with pulmonary hypertension (PH). Combined with clinical assessment, they offer the possibility to reduce the frequency of traditional, time-consuming, complex, and costly tests. Echocardiography, right heart catheterization (RHC), or cardiac magnetic resonance (CMR) could then be reserved for detailed initial evaluation and for resolving more complex emerging clinical problems. Biomarkers would be particularly useful for outpatient monitoring and daily clinical practice. Our paper reviews the evidence collected so far in this dynamically developing area of cardiovascular medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据